🔎 Trials Near Me

Inicio › Diabetes tipo 2 › Pensilvania

Ensayos clínicos de Diabetes tipo 2 en Pensilvania

30 estudios sobre Diabetes tipo 2 buscan participantes en Pensilvania.

Ciudades en Pensilvania

Texto oficial del estudio (inglés)

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Capital Area Research, Camp Hill
ReclutandoSe aceptan voluntarios sanos
Edades de 55 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06112418

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Suburban Research Associates, West Chester
  • Cardiology Consultants of Philadelphia Yardley, Yardley
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07783802

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Scottdale
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh
  • Preferred Primary Care Physicians, Uniontown
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07282600

Phenotyping Genetic Risk for Type 2 Diabetes

  • Childrens Hospital of Philadelphia, Philadelphia
  • University of Pennsylvania, Philadelphia
ReclutandoSe aceptan voluntarios sanos
Edades de 10 a 70 · Todos los sexos · Actualizado el 21 sept 2026 · NCT04024631

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Heritage Valley Medical Group, Beaver
  • Preferred Primary Care Physicians-Pittsburgh-63932, Pittsburgh
  • Preferred Primary Care Physicians, Pittsburgh
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07754461

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Philadelphia
  • AURORA-2 Clinical Site, Pittsburgh
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Heritage Valley Medical Group, Beaver
  • Capital Area Research, LLC, Camp Hill
  • Thomas Jefferson University, Philadelphia
  • y 8 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07064473

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • VA Pittsburgh Healthcare System, Pittsburgh
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Frontier Clinical Research, LLC, Scottdale
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 14 sept 2026 · NCT06897475

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Northeast Clinical Research Center, Bethlehem
  • Suburban Research Associates, West Chester
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  • Preferred Primary Care Physicians, Inc., Uniontown
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Feasterville-Trevose
  • Research Site, Philadelphia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07662213

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • Children's Hosptl Philadelphia, Philadelphia
ReclutandoFase 3
Edades de 10 a 18 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07282613

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Suburban Research Associates, West Chester
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07296484

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • Heritage Valley Medical Group, Beaver
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 31 ago 2026 · NCT07564414

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Children's Hospital of Philadelphia, Philadelphia
  • St Christophers Hospital For Children, Philadelphia
ReclutandoFase 3
Edades de 10 a 17 · Todos los sexos · Actualizado el 7 ago 2026 · NCT06739122

The GRoceries Aimed at Increasing Nutrition Study

  • University of Pennsylvania, Philadelphia
ReclutandoIndica pago para participantes
Edades de 45 a 70 · Todos los sexos · Actualizado el 6 ago 2026 · NCT07167004

Pharmacogenetics of Response to GLP1R Agonists

  • Amish Research Clinic, Lancaster
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 89 · Todos los sexos · Actualizado el 27 jul 2026 · NCT05071898

Sleep and Glycemic Control in Type 2 Diabetes Adolescents

  • Children's Hospital of Philadelphia, Philadelphia
Reclutando
Edades de 12 a 20 · Todos los sexos · Actualizado el 29 jun 2026 · NCT04213547

CGM for Management of Type 2 Diabetes in Pregnancy

  • University of Pennsylvania, Philadelphia
Reclutando
Edades de 18 a 50 · Mujeres · Actualizado el 29 jun 2026 · NCT06628453

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

  • Children's Hospital of Philadelphia, Philadelphia
ReclutandoEstudio observacional
Edades de 8 a 15 · Todos los sexos · Actualizado el 7 may 2026 · NCT06525259

Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
ReclutandoSe aceptan voluntarios sanos
Edades de 13 en adelante · Todos los sexos · Actualizado el 27 abr 2026 · NCT07216118

Transformative Research in Diabetic Nephropathy 2.0

  • Penn Presbyterian Medical Center, Philadelphia
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 mar 2026 · NCT07444203

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

  • Children's Hospital of Pittsburgh, Pittsburgh
Reclutando
Edades de 16 a 24 · Todos los sexos · Actualizado el 20 feb 2026 · NCT07270016

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 12 a 17 · Todos los sexos · Actualizado el 18 dic 2025 · NCT05277558

CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

  • Thomas Jefferson University, Philadelphia
Reclutando
Edades de 18 en adelante · Mujeres · Actualizado el 14 oct 2025 · NCT07184775

Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes

  • Reading Hospital, an affiliate of Tower Health, West Reading
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 jul 2025 · NCT05893927

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.